Review Guidelines for Obesity: Explore Pharmacological Treatment Options
In the first part of our two-part panel discussion, listen to our guest speaker Prof. Mei-Yueh Lee discussing guideline recommendations for weight reduction goals. She covers the AGA 2022 Guideline and reviews the NICE 2025 Guideline Recommendations and provides an update on the status of several pharmacological treatment options, including orlistat, semaglutide, naltrexone/bupropion, liraglutide, and tirzepatide.